CDNA · Caredx Inc
United States · RS rating 99 · As of 2026-10-14
| Price | 64.69 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 97 / 96 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 53 / 57 / 52 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +162.5% |
| Sales growth Q/Q | +8.3% |
| Distance from 52-week high | +7.4% |
| Market cap (USD) | $1.0B |